ConductScience.org, home

Paper30384792

Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.

Grosse SD and 2 others. J Med Econ, 2019. Cited by 80 papers, by iCite.

Cite this record

ConductScience Library. Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations. Papers, record 30384792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30384792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.
PubMed
Journal
J Med Econ
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
4.15
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grosse SDScott D
2Krueger KVKurt V
3Pike JJamison

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cost of IllnessMajor topic
EfficiencyMajor topic
Models, EconomicMajor topic
Salaries and Fringe BenefitsMajor topic
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Censuses
Female
Humans
Life Tables
Male
Middle Aged
United States
Young Adult

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CC999999Intramural CDC HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in30821543Correction.https://conductscience.org/library/papers/30821543

Source PubMed

Download CSV of comments and corrections

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110520672Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.Med Decis Making1999https://conductscience.org/library/papers/10520672PubMed
212055046Economic gains resulting from the reduction in children's exposure to lead in the United States.Environ Health Perspect2002https://conductscience.org/library/papers/12055046PubMed
315748084Friction-cost method as an alternative to the human-capital approach in calculating indirect costs.Pharmacoeconomics2005https://conductscience.org/library/papers/15748084PubMed
416942122Cost-of-illness studies : a review of current methods.Pharmacoeconomics2006https://conductscience.org/library/papers/16942122PubMed
519536021Economic productivity by age and sex: 2007 estimates for the United States.Med Care2009https://conductscience.org/library/papers/19536021PubMed
619654928Childhood lead poisoning: conservative estimates of the social and economic benefits of lead hazard control.Environ Health Perspect2009https://conductscience.org/library/papers/19654928PubMed
719807446Cost-of-illness analyses for policy making: a cautionary tale of use and misuse.Expert Rev Pharmacoecon Outcomes Res2003https://conductscience.org/library/papers/19807446PubMed
819995754The value of productivity: human-capital versus friction-cost method.Ann Rheum Dis2010https://conductscience.org/library/papers/19995754PubMed
921146909Measuring and valuing productivity loss due to poor health: A critical review.Soc Sci Med2011https://conductscience.org/library/papers/21146909PubMed
102148306The lifetime cost of injury.Inquiry1990https://conductscience.org/library/papers/2148306PubMed
1121545189Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.Pharmacoeconomics2011https://conductscience.org/library/papers/21545189PubMed
1221604822Cost-of-illness studies: a guide to critical evaluation.Pharmacoeconomics2011https://conductscience.org/library/papers/21604822PubMed
1322188353Economic burden of occupational injury and illness in the United States.Milbank Q2011https://conductscience.org/library/papers/22188353PubMed
1424504850How to estimate productivity costs in economic evaluations.Pharmacoeconomics2014https://conductscience.org/library/papers/24504850PubMed
1525781999The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.PLoS One2015https://conductscience.org/library/papers/25781999PubMed
1625876834A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.Eur J Health Econ2016https://conductscience.org/library/papers/25876834PubMed
1726385101Cost-of-Illness Studies: An Updated Review of Current Methods.Pharmacoeconomics2016https://conductscience.org/library/papers/26385101PubMed
1827161997Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.Vaccine2016https://conductscience.org/library/papers/27161997PubMed
1927623463Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.JAMA2016https://conductscience.org/library/papers/27623463PubMed
2027873305Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.Health Serv Res2018https://conductscience.org/library/papers/27873305PubMed

See all 28 referencesDownload CSV of references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
42771343Cost of a Measles Outbreak in an Urban Shelter.JAMA Netw Open2026https://conductscience.org/library/papers/42771343PubMed
42617888Morbidity-Related Productivity Losses From Major Depressive Disorder Among U.S. Adults.Am J Prev Med2026https://conductscience.org/library/papers/42617888PubMed
42466506Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Methamphetamine-Associated Heart Failure in the United States.J Am Heart Assoc2026https://conductscience.org/library/papers/42466506PubMed
42188782Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States.Vaccines (Basel)2026https://conductscience.org/library/papers/42188782PubMed
42154427Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis.Infect Dis Ther2026https://conductscience.org/library/papers/42154427PubMed
42099551Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study.Lancet Reg Health Am2026https://conductscience.org/library/papers/42099551PubMed
42071110Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities from a Targeted Literature Review and Expert Workshop.Pharmacoecon Open2026https://conductscience.org/library/papers/42071110PubMed
41823143The broad societal value of pembrolizumab for women's cancer in Canada.Future Oncol2026https://conductscience.org/library/papers/41823143PubMed
41746506Cost-Effectiveness of Nirsevimab and Clesrovimab in Preventing Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Modeling Study.Infect Dis Ther2026https://conductscience.org/library/papers/41746506PubMed
41364049Productivity Losses From Substance Use Disorder in the U.S. in 2023.Am J Prev Med2026https://conductscience.org/library/papers/41364049PubMed
41345602Modelling the epidemiological impact and cost-effectiveness of possible changes to the meningococcal vaccination schedule for adolescents and young adults in the United States.BMC Public Health2025https://conductscience.org/library/papers/41345602PubMed
41288194Estimating Productivity Losses per HIV Infection due to Premature HIV Mortality in the United States.Med Decis Making2026https://conductscience.org/library/papers/41288194PubMed
41075052Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50-59 Years at Increased Risk of Severe RSV Disease.Infect Dis Ther2025https://conductscience.org/library/papers/41075052PubMed
40721584Cost-effectiveness of chikungunya vaccination with the live attenuated vaccine in U.S. territories.NPJ Vaccines2025https://conductscience.org/library/papers/40721584PubMed
40699573Optimizing Timing for Respiratory Syncytial Virus Prevention Interventions for Infants.JAMA Netw Open2025https://conductscience.org/library/papers/40699573PubMed
40553408Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations.Pharmacoecon Open2025https://conductscience.org/library/papers/40553408PubMed
40455586Economic burden of fungal diseases in the United States.Med Mycol2025https://conductscience.org/library/papers/40455586PubMed
40394570Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach.BMC Public Health2025https://conductscience.org/library/papers/40394570PubMed
40285335The "Stock of Time" Method: A New Approach to Calculate Indirect Costs and Benefits in Economic Evaluations.Med Decis Making2025https://conductscience.org/library/papers/40285335PubMed
40220866Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States.Value Health2025https://conductscience.org/library/papers/40220866PubMed

See all 51 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30384792

GET https://conductscience.org/api/papers/v1/30384792/references?page=2